Royal Bank Of Canada reiterated their buy rating on shares of HealthSouth Corporation (NYSE:HLS) in a report published on Wednesday morning. They currently have a $55.00 target price on the stock.

Several other analysts have also recently commented on HLS. Piper Jaffray Companies restated a hold rating and issued a $50.00 target price on shares of HealthSouth Corporation in a research report on Thursday, August 3rd. Mizuho raised their target price on HealthSouth Corporation from $44.00 to $47.00 and gave the company a neutral rating in a research report on Monday, July 10th. Zacks Investment Research upgraded HealthSouth Corporation from a hold rating to a buy rating and set a $49.00 target price on the stock in a research report on Wednesday, August 2nd. ValuEngine cut HealthSouth Corporation from a buy rating to a hold rating in a research report on Friday, September 1st. Finally, KeyCorp began coverage on HealthSouth Corporation in a research report on Thursday, June 15th. They issued a sector weight rating on the stock. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of Hold and a consensus price target of $49.71.

HealthSouth Corporation (HLS) traded down 0.51% during mid-day trading on Wednesday, hitting $44.73. The company had a trading volume of 642,452 shares. The stock’s 50 day moving average price is $44.10 and its 200 day moving average price is $44.79. The firm has a market cap of $4.42 billion, a P/E ratio of 16.30 and a beta of 0.59. HealthSouth Corporation has a 52-week low of $36.97 and a 52-week high of $49.71.

HealthSouth Corporation (NYSE:HLS) last posted its earnings results on Monday, July 31st. The company reported $0.71 EPS for the quarter, beating the consensus estimate of $0.68 by $0.03. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The firm had revenue of $981.30 million for the quarter, compared to analysts’ expectations of $976.46 million. During the same period last year, the firm earned $0.69 EPS. The firm’s revenue was up 6.6% compared to the same quarter last year. On average, equities research analysts predict that HealthSouth Corporation will post $2.71 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Royal Bank Of Canada Reaffirms Buy Rating for HealthSouth Corporation (HLS)” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.thecerbatgem.com/2017/09/09/royal-bank-of-canada-reaffirms-buy-rating-for-healthsouth-corporation-hls.html.

The company also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Monday, October 2nd will be paid a dividend of $0.25 per share. This is a positive change from HealthSouth Corporation’s previous quarterly dividend of $0.24. This represents a $1.00 dividend on an annualized basis and a yield of 2.24%. The ex-dividend date is Friday, September 29th. HealthSouth Corporation’s dividend payout ratio (DPR) is presently 35.29%.

In other HealthSouth Corporation news, CEO Mark J. Tarr sold 22,625 shares of the stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $42.55, for a total transaction of $962,693.75. Following the completion of the transaction, the chief executive officer now directly owns 283,134 shares of the company’s stock, valued at approximately $12,047,351.70. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.60% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. boosted its stake in HealthSouth Corporation by 4.6% during the 2nd quarter. Vanguard Group Inc. now owns 7,532,456 shares of the company’s stock valued at $364,571,000 after purchasing an additional 328,081 shares in the last quarter. William Blair Investment Management LLC boosted its stake in HealthSouth Corporation by 13.9% during the 2nd quarter. William Blair Investment Management LLC now owns 4,302,756 shares of the company’s stock valued at $208,253,000 after purchasing an additional 525,767 shares in the last quarter. State Street Corp boosted its stake in HealthSouth Corporation by 7.5% during the 2nd quarter. State Street Corp now owns 3,129,781 shares of the company’s stock valued at $151,479,000 after purchasing an additional 219,306 shares in the last quarter. Voya Investment Management LLC boosted its stake in HealthSouth Corporation by 4.4% during the 2nd quarter. Voya Investment Management LLC now owns 1,621,585 shares of the company’s stock valued at $78,485,000 after purchasing an additional 68,486 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in HealthSouth Corporation by 1.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,458,636 shares of the company’s stock valued at $70,597,000 after purchasing an additional 23,480 shares in the last quarter. 93.10% of the stock is owned by hedge funds and other institutional investors.

About HealthSouth Corporation

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Analyst Recommendations for HealthSouth Corporation (NYSE:HLS)

Receive News & Stock Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related stocks with our FREE daily email newsletter.